Unmet Needs in IPF Landscape
Critical voids in the management of idiopathic pulmonary fibrosis are discussed by Justin Oldham, MD, MS.
Economic Impact of IPF
The panel explores how IPF affects patient productivity and its contribution to the disease's overall economic burden.
Key Considerations for Selecting IPF Treatment
Decision-making factors surrounding optimal IPF treatment selection are evaluated by Justin Oldham, MD, MS.
Therapeutic Response and Disease Progression
An expert on idiopathic pulmonary fibrosis describes the therapeutic response of standard-of-care treatments and how multidisciplinary care can be optimized when treating patients.
Current Standard of Care in IPF
Justin Oldham, MD, MS, discusses the current standard of car in treating idiopathic pulmonary fibrosis and the role of non-pharmacologic therapies.
